Appearance and Shape (20°C) | Solid |
---|---|
CAS RN | 21256-18-8 |
MDL number | MFCD00215977 |
Molecular weight | 293.32 |
Molecular Formula | C18H15NO3 |
Product code | ICTO0377 |
PubChem Substance ID | 160871033 |
Purity/Analytical Methods | >98.0%(T)(HPLC) |
Reaxys-RN | 1083168 |
SDBS (AIST Spectral DB) | 53268 |
Appearance | White to Almost white powder to crystal |
---|
Hazard statement | H413 : May cause long lasting harmful effects to aquatic life. |
---|---|
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P273 : Avoid release to the environment. |
RTECS# | RP6990000 |
---|
Chemicals by Class 5-Membered Heterocyclic Compounds [Chemical Structural Class] Oxazoles [Chemical Structural Class]
Life Science Biochemicals and Reagents Enzymes, Enzyme Inhibitors, Enzyme Substrates Cyclooxygenase (COX) [by Application] Enzyme Inhibitors [Biochemicals and Reagents] Enzyme Inhibitors [A to C] Cyclooxygenase (COX) Inhibitors Enzyme Inhibitors [P to Q] Prostaglandin H Synthetases 1 (COX-1) and 2 (COX-2) Inhibitors Enzyme Inhibitors by Enzyme Enzymes [by Application] Cyclooxygenase (COX) Inhibitors Pharmaceutical Ingredients (for Research and Experimental Use) Anti-inflammatory Ingredients (for Research and Experimental Use) Anti-rheumatoid Arthritis Ingredients (for Research and Experimental Use) Non-Steroidal Anti-Inflammatories (NSAIDs) Non-steroidal Anti-inflammatory Agents (NSAIDs) Cell Biology Immune System, Inflammation, Allergy Research Cyclooxygenase (COX) Inhibitors Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Anti-inflammatory Ingredients (for Research and Experimental Use) Anti-rheumatoid Arthritis Ingredients (for Research and Experimental Use) Non-Steroidal Anti-Inflammatories (NSAIDs) Non-steroidal Anti-inflammatory Agents (NSAIDs)